Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Current therapeutic approaches in metastatic and recurrent Ewing Sarcoma
Michael Huang
, Kenneth Lucas
Division of Hematology & Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
32
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current therapeutic approaches in metastatic and recurrent Ewing Sarcoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ewing Sarcoma
100%
Therapeutic Approaches
100%
Current Therapeutics
100%
Survival Rate
50%
Older Adults
25%
Chemotherapy
25%
Primary Bone
25%
Salvage Chemotherapy
25%
Local Control
25%
Stem Cell Transplantation
25%
Chemotherapy Regimen
25%
Most Common Form
25%
Upfront Chemotherapy
25%
Bone Malignancy
25%
Stem Cell Potential
25%
Medicine and Dentistry
Ewing Sarcoma
100%
Survival Rate
50%
Cancer
25%
Immunotherapy
25%
Stem Cell Therapy
25%
Cell Membrane Potential
25%
Chemotherapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ewing Sarcoma
100%
Survival Rate
50%
Chemotherapy
50%
Immunotherapy
25%